Emergency medicine

Penn Highlands Healthcare Doctors Beyond the Borders

Retrieved on: 
Wednesday, March 20, 2024
MSUCOM, Famine, Forward surgical teams, Osteopathy, Hamas, The, Clinical professor, Patient, Trauma, Sports medicine, Medical director, Nursing, Research, Orthopedic surgery, Education, Samaritan's Purse, Woman, Water quality, General surgery, Emergency medicine, Injury, FACS, Altitude, EVP, Disease, Hospital, Poverty, Family, DOCARE, Universidad, Global Health, Firefighter, Physician, International health, Medicine

Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.

Key Points: 
  • Penn Highlands Healthcare offers 849 physicians who provide a wide range of care and treatments at locations throughout 26 counties in Pennsylvania.
  • Penn Highlands Healthcare physicians can be found in the health system’s eight hospitals as well as many community medical buildings, outpatient facilities, surgery centers and physician practices.
  • Some Penn Highlands Healthcare physicians do not allow county, state or continental borders to keep them from providing care where it is needed.
  • Dr. Sergent, who is an emergency medicine physician and the Central Region Medical Director of Emergency Medicine at Penn Highlands Healthcare, shares his skills and expertise beyond the U.S. borders in Central and South America.

Nathan Kuppermann, M.D., M.P.H., named chief academic officer and chair of Pediatrics at Children’s National Hospital

Retrieved on: 
Wednesday, March 13, 2024
JAMA, Research, Health care, Health, Public, Public health, EVP, UCSF School of Medicine, Pediatric Research, Education, UC, Global Health, Emergency medicine, Society, Publication, Emergency medical services, Hospital, Children's National Hospital, Stanford University, National academy, MHA, Pediatrics, BMJ

Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Nathan Kuppermann, M.D., M.P.H., as its new executive vice president (EVP), chief academic officer (CAO) and chair of Pediatrics.

Key Points: 
  • Washington, D.C., March 13, 2024 (GLOBE NEWSWIRE) -- Children's National Hospital has appointed Nathan Kuppermann, M.D., M.P.H., as its new executive vice president (EVP), chief academic officer (CAO) and chair of Pediatrics.
  • He comes to Children’s National from UC Davis Health and UC Davis School of Medicine in Sacramento, CA, and will start in September.
  • After a national search, Dr. Kuppermann stood out for his exceptional contributions to clinical and academic research, focusing on pediatric emergency care, and his dedication to mentorship.
  • He completed a pediatrics residency and chief residency at Harbor-UCLA Medical Center and a fellowship in Pediatric Emergency Medicine at Boston Children's Hospital.

Genetesis Announces Formal Publication of Results from the MAGNETO Trial

Retrieved on: 
Tuesday, April 2, 2024
Health, Other Health, General Health, Clinical Trials, Research, Science, Cardiology, Radiation, Ascension Michigan, Dipyridamole, Moyamoya disease, Risk, Patient, Emergency medicine, Guideline, Ischemia, MD, Publication, FACEP, ED, Medical director, MCG, Medical device

Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .

Key Points: 
  • Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .
  • The results of MAGNETO demonstrate MCG’s ability to identify myocardial ischemia in low-to-intermediate risk patients presenting to the emergency department (ED) with acute chest pain and validate MCG’s performance compared to tests that comprise the current standard of care.
  • “To the extent of my awareness, this constitutes the most extensive MCG trial conducted in the past 60 years, dating back to the inception of MCG research.
  • Additional analyses of data collected in the MAGNETO trial are also planned for publication in the same special issue where topline results have just been published.

Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection

Retrieved on: 
Wednesday, March 27, 2024
Other Health, Research, General Health, Pharmaceutical, University, Education, Clinical Trials, Science, Biotechnology, FDA, Other Science, Health, Hypoventilation, Hypersensitivity, Nalmefene, IIR, Pulmonary edema, Doctor of Pharmacy, University of New Mexico, Safety, Tachycardia, Risk, Patient, Hydrogen chloride, Purdue Pharma, Naloxone, UNM, Emergency medicine, Ventricular tachycardia, Mortality, Buprenorphine, MD, Methadone, Emergency department, Ventricular fibrillation, Hypotension, Oxygen, HCI, ED, Hypertension, Recurrence, LAAM, Opioid overdose, Purdue University, Pharmaceutical industry

“We are enthusiastic about supporting research that can contribute to addressing the opioid overdose crisis.”

Key Points: 
  • “We are enthusiastic about supporting research that can contribute to addressing the opioid overdose crisis.”
    The prospective, randomized study, “Evaluation of Nalmefene HCl Injection for Recurrent Respiratory Depression After Suspected Acute Opioid Overdose in an Emergency Department,” will compare the efficacy and safety of nalmefene HCl injection to naloxone injection in the treatment of recurrent respiratory depression due to opioid overdose.
  • Nalmefene HCl injection is an opioid antagonist indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids and in the management of known or suspected opioid overdose.
  • Nalmefene Hydrochloride injection is contraindicated in patients with a known hypersensitivity to the product.1 The Company distributes nalmefene HCl injection for no profit.
  • The study will be independently developed and carried out by UNM’s research team with Purdue Pharma providing only funding and nalmefene HCI injection.

Nym Named Among Top 25 Companies in Healthcare Software for 2024 by The Healthcare Technology Report

Retrieved on: 
Thursday, March 21, 2024
Health, Technology, Hospitals, Practice Management, Health Technology, Software, Radiology, Emergency medicine, Risk, CLU, Organization, Creativity, Research, News

Nym, the leader in autonomous medical coding, today announced that it has been named among the Top 25 Healthcare Software Companies of 2024 by The Healthcare Technology Report .

Key Points: 
  • Nym, the leader in autonomous medical coding, today announced that it has been named among the Top 25 Healthcare Software Companies of 2024 by The Healthcare Technology Report .
  • A leader in healthcare sector news, The Healthcare Technology Report delivers insights to over 60,000 executives and aspiring professionals in the industry.
  • “This award recognizes leaders in the software space who are driving meaningful change via innovation and bolstering the efforts of healthcare organizations across the industry,” said Or Peles, Nym’s CEO.
  • Additional information about The Healthcare Technology Report’s Top 25 Healthcare Software Companies of 2024, including the full list of winners, can be found here .

Regence BlueCross BlueShield of Utah Welcomes Mike Woodruff, M.D., as Its Executive Medical Director

Retrieved on: 
Monday, March 18, 2024
Professional Services, Health, Insurance, Practice Management, Health Insurance, General Health, Cambia Health Solutions, Woodruff, Surgeon, Trust, National Quality Forum, Knowledge, Intermountain Health, University, Patient, American Hospital Association, Workforce, Patient safety, Emergency medicine, Physician, Multimedia, Nursing

Regence BlueCross BlueShield of Utah welcomes Dr. Mike Woodruff as its new executive medical director.

Key Points: 
  • Regence BlueCross BlueShield of Utah welcomes Dr. Mike Woodruff as its new executive medical director.
  • In this executive leadership role, he will drive clinical strategies focused on improving health care access, affordability, quality and member experience.
  • “Woodruff has a strong track record of implementing simple, user-friendly interventions that build trust and provide meaningful value,” said Jim Guemple, president of Regence BlueCross BlueShield of Utah.
  • He received his residency training at the University of Utah and Beth Israel Deaconess Medical Center in Boston.

California University of Science and Medicine Celebrates Match Day for 2024 MD Graduates

Retrieved on: 
Friday, March 15, 2024
Technology, Nursing, Hospitals, Software, Other Health, Managed Care, Health, University, Education, Internal medicine, Inland Empire, Psychiatry, Family medicine, Emergency medicine, Match Day, MD, Student, Multimedia

California University of Science and Medicine (CUSM) today announced that the 2024 MD graduating class received residency placements as part of the national Match Day event.

Key Points: 
  • California University of Science and Medicine (CUSM) today announced that the 2024 MD graduating class received residency placements as part of the national Match Day event.
  • Match Day is the culmination of the National Resident Matching Program, in which all graduating MDs seek residency positions in their chosen specialty.
  • But Match Day is the most emotional and fulfilling day of the medical school journey," said Paul Lyons, MD, CUSM Dean and President.
  • CUSM Match Day 2024 Breakdown:
    Top specialties include Internal Medicine, Family Medicine, Emergency Medicine, and Psychiatry

MedStar Health and DispatchHealth Launch Exclusive Partnership to Provide Acute Care at Home in Washington, D.C.

Retrieved on: 
Thursday, April 4, 2024
EDS, Innovation, Pneumonia, Practitioner, Caregiver, Partnership, MedStar Health, MedSTAR, Risk, COVID-19, Health, Patient, Education, MedStar Georgetown University Hospital, MD, Dehydration, Urinary tract infection, Emergency medicine, COPD, MedStar Washington Hospital Center, Multimedia

"MedStar Health is committed to expanding the continuity of the safest and highest quality care through a unique new partnership in Washington, D.C.," says Ethan Booker, MD , chief medical officer for telehealth at MedStar Health and a leader of MedStar Institute for Innovation.

Key Points: 
  • "MedStar Health is committed to expanding the continuity of the safest and highest quality care through a unique new partnership in Washington, D.C.," says Ethan Booker, MD , chief medical officer for telehealth at MedStar Health and a leader of MedStar Institute for Innovation.
  • This at-home acute care service is preventing hospital returns by providing care that can be managed in a patient's own home, such as medication management.
  • DispatchHealth securely sends information and follow-up requests from visits with the patients' care teams at MedStar Health.
  • "It's a privilege to collaborate with MedStar Health and its high-quality care teams through this partnership."

The Inner Circle acknowledges Antony Jackson Arumairaj, MD as a Top Pinnacle Physician

Retrieved on: 
Tuesday, April 2, 2024
College, Research, American Medical Association, Royal Australasian College, Internal medicine, Critical Care Medicine (journal), Patient, Publishing, Emergency medicine, MD, American College of Physicians, Mentorship, Royal college, American Thoracic Society, Society, Bachelor, American College, Stanley Medical College, Internship, Multimedia, Health, Inner circle, Teaching, Nursing

JERSEY CITY, N.J., April 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Antony Jackson Arumairaj, MD is acknowledged as a Top Pinnacle Physician for his contributions as a Distinguished Internal Medicine Specialist.

Key Points: 
  • JERSEY CITY, N.J., April 2, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Antony Jackson Arumairaj, MD is acknowledged as a Top Pinnacle Physician for his contributions as a Distinguished Internal Medicine Specialist.
  • In this capacity, he not only provides exceptional patient care but also plays a pivotal role in teaching and mentoring medical students.
  • His dedication to the well-being of his patients and commitment to medical education make him a valuable asset to the healthcare community.
  • He aims to complete his Pulmonary Critical Care fellowship and become an Attending Physician at a university hospital.

HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device

Retrieved on: 
Tuesday, April 2, 2024
Annals of Emergency Medicine, Veteran, Headache (journal), Headache, Patient, American Journal, Emergency medicine, McMaster University, University, Software, Migraine, OTC, Ohio State University, Multimedia, University of Toronto, FDA, Food, Medical device

Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.

Key Points: 
  • Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users.
  • HeadaTerm 2 is a testament of WAT Medical's continued commitment to providing safe, effective, and user-friendly innovative medical devices at the most competitive price.
  • It provided an affordable solution to a debilitating condition that affects nearly 40 million people in the U.S. HeadaTerm 2 is a rechargeable device that features adjustable intensity setting and will be the most affordable device of its kind.
  • HeadaTerm 2 will appear at the 66th Annual Scientific Meeting in June 2024 hosted by American Headache Society.